Does self-monitoring blood glucose improve outcomes in patients with type 2 diabetes not taking insulin?

    loading  Checking for direct PDF access through Ovid

Abstract

EVIDENCE-BASED ANSWER

In patients with type 2 diabetes (T2DM) not requiring insulin, self-monitoring of blood glucose (SMBG) has inconsistent effects on patient-oriented outcomes such as quality of life (QOL), hypoglycemia, and patient satisfaction. The effect of SMBG is also inconsistent on all-cause mortality and diabetic complications. SMBG is associated with small but clinically insignificant reductions in hemoglobin A1C (HbA1C) (SOR: C, metaanalysis of RCTs with disease-oriented outcomes).

Related Topics

    loading  Loading Related Articles